Back to Search

ANGELA BRANDES, MD

MD

Family Medicine Physician

NPI: 1073791703IndividualAccepts Medicare

Specialties, Licenses & Credentials

Family Medicine PhysicianPrimary

Family Medicine

Code: 207Q00000X

51156(WI)

CMS Specialties

PrimaryFAMILY PRACTICE

Education

OTHER

Class of 2006

Research & Publications (20)

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
PMID 19169684·Cancer Chemother Pharmacol·2009
3-trial
Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status.
PMID 19188675·J Clin Oncol·2009
8-other
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.
PMID 19514084·Cancer·2009
8-other
Does bipolar pacemaker current activate blood platelets?
PMID 19422584·Pacing Clin Electrophysiol·2009
8-other
Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.
PMID 19204207·J Clin Oncol·2009
3-trial
Pneumococcal capsular polysaccharide structure predicts serotype prevalence.
PMID 19521509·PLoS Pathog·2009
7-preclinical
An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): data report from Italy.
PMID 18951651·Lung Cancer·2009
3-trial
Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET).
PMID 19303318·Crit Rev Oncol Hematol·2009
6-review
Treatment options for recurrent glioblastoma: pitfalls and future trends.
PMID 19445578·Expert Rev Anticancer Ther·2009
6-review
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
PMID 19269895·Lancet Oncol·2009
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
2651 HILLCREST DRIVE
HUDSON, WI 54016

Locations (2)

Practice Location

2651 HILLCREST DRIVE, HUDSON, WI
(715) 531-6800

Practice Location

525 N. KNOWLES AVE, NEW RICHMOND, WI
(715) 531-6800

Quick Facts

NPI
1073791703
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
1
Locations
2
Years in Practice
20
Publications
20

Are you this provider?

Claim Your Profile